Help create a future where no man like Mark has to face the heartbreak of learning their cancer is incurable.
Please donate now to fund urgent research to make life-saving treatments like Lutetium PSMA available to men sooner.
Please donate urgently now
Mark never imagined he’d hear the words “You have prostate cancer.”
He felt healthy. Sure, he had a few minor symptoms – a slower stream, some aches and pains – but he assumed they were just part of turning 50.
Mark's treatment began with hope, but as the months passed, that hope faded.
The cancer had spread, and, over time, it became resistant to the treatments.
“After surgery, they found it in my lymph nodes. I started treatment, but when my PSA levels went up again, I knew this wasn’t going to be easy,” Mark said
The constant barrage of treatments drained him – not just physically, but emotionally. His energy, independence, and sense of self began to slip away.
Mark is now running out of options. But his story could have been different if Lutetium PSMA therapy had been available to him earlier.
Late last year, research newly published in The Lancet reported that when Lutetium PSMA was used up front for men with aggressive prostate cancer, higher numbers of men had undetectable PSA levels 48 weeks later.
And with no increased risk of toxic side effects.
Unfortunately, Lutetium PSMA therapy is only available on compassionate grounds, for men who have exhausted all other treatment options.
Lutetium PSMA must be moved from a treatment of last resort to a first line defence against prostate cancer, to save the lives of Australian men like Mark.
Will you please donate now to fund critical follow up research that will establish Lutetium PSMA as the standard of care for men?
Mark never imagined he’d hear the words “You have prostate cancer.”
He felt healthy. Sure, he had a few minor symptoms – a slower stream, some aches and pains – but he assumed they were just part of turning 50.
Mark's treatment began with hope, but as the months passed, that hope faded.
The cancer had spread, and, over time, it became resistant to the treatments.
No man or his family should have to face the agony of a deadly prostate cancer diagnosis.
But the tragic reality is that 3,901 Australian men lose their lives to the disease every year.
1 in 5 men are likely to be
diagnosed by 85
Around 26,000 men are
diagnosed each year
11 men die each day
from
prostate cancer
By making a generous donation you can help support clinical trials that will show using Lutetium PSMA earlier in treatment will save lives.
Australian researchers are accelerating work on the development of next generation treatments in the fight against prostate cancer, with a new PCFA funded project set to support men battling metastatic disease.
No man should have to face the heartbreak
of a deadly prostate cancer diagnosis.
The follow up research must start now in order to prove the power of Lutetium PSMA for men in our community like Mark. You can help make that happen.
